Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Johnson & Johnson logoJohnson & Johnson JNJ

The company said reported sales for Q3 2024 rose to $22,471 million, up 5.2% from $21,351 million a year earlier. Operational growth was 6.3%, and adjusted operational growth was 5.4%.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said reported sales for Q3 2024 rose to $22,471 million, up 5.2% from $21,351 million a year earlier. Operational growth was 6.3%, and adjusted operational growth was 5.4%.

  2. The company said net earnings for Q3 fell to $2,694 million, down 37.5% from $4,309 million a year earlier, and diluted EPS fell 34.3% to $1.11. It cited a one-time special charge and acquired IPR&D as factors. Adjusted EPS fell 9.0% to $2.42.

  3. The company set its midpoint full-year adjusted operational EPS outlook at $9.91, versus its prior outlook of $10.05. It said the change reflects improved performance outlook of $0.10 and the impact of the V-Wave acquisition ($0.24).

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call. Some paragraphs were omitted because their support in the source could not be confirmed.

Johnson & Johnson Reports Q3 2024 Reported Sales of $22,471 million

The company said reported sales for Q3 2024 rose to $22,471 million, up 5.2% from $21,351 million a year earlier. Operational growth was 6.3%, and adjusted operational growth was 5.4%.

Source · Based on the filing body and exhibits

Q3 Net Earnings and Adjusted EPS Decline

The company said net earnings for Q3 fell to $2,694 million, down 37.5% from $4,309 million a year earlier, and diluted EPS fell 34.3% to $1.11. It cited a one-time special charge and acquired IPR&D as factors. Adjusted EPS fell 9.0% to $2.42.

Source · Based on the filing body and exhibits

Full-Year Adjusted Operational EPS Outlook $9.91

The company set its midpoint full-year adjusted operational EPS outlook at $9.91, versus its prior outlook of $10.05. It said the change reflects improved performance outlook of $0.10 and the impact of the V-Wave acquisition ($0.24).

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.